BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33363466)

  • 1. Ginsenoside Compound K Regulates HIF-1α-Mediated Glycolysis Through Bclaf1 to Inhibit the Proliferation of Human Liver Cancer Cells.
    Zhang S; Zhang M; Chen J; Zhao J; Su J; Zhang X
    Front Pharmacol; 2020; 11():583334. PubMed ID: 33363466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bclaf1 promotes angiogenesis by regulating HIF-1α transcription in hepatocellular carcinoma.
    Wen Y; Zhou X; Lu M; He M; Tian Y; Liu L; Wang M; Tan W; Deng Y; Yang X; Mayer MP; Zou F; Chen X
    Oncogene; 2019 Mar; 38(11):1845-1859. PubMed ID: 30367150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bclaf1 is a direct target of HIF-1 and critically regulates the stability of HIF-1α under hypoxia.
    Shao A; Lang Y; Wang M; Qin C; Kuang Y; Mei Y; Lin D; Zhang S; Tang J
    Oncogene; 2020 Mar; 39(13):2807-2818. PubMed ID: 32029898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCLAF1-induced HIF-1α accumulation under normoxia enhances PD-L1 treatment resistances via BCLAF1-CUL3 complex.
    Yao B; Lu Y; Li Y; Bai Y; Wei X; Yang Y; Yao D
    Cancer Immunol Immunother; 2023 Dec; 72(12):4279-4292. PubMed ID: 37906282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Honokiol Inhibits HIF-1α-Mediated Glycolysis to Halt Breast Cancer Growth.
    Yi X; Qi M; Huang M; Zhou S; Xiong J
    Front Pharmacol; 2022; 13():796763. PubMed ID: 35350760
    [No Abstract]   [Full Text] [Related]  

  • 6. Ginsenoside CK Inhibits Hypoxia-Induced Epithelial-Mesenchymal Transformation through the HIF-1α/NF-κB Feedback Pathway in Hepatocellular Carcinoma.
    Zhang J; Ma X; Fan D
    Foods; 2021 May; 10(6):. PubMed ID: 34073155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ginsenoside compound K inhibits growth of lung cancer cells via HIF-1α-mediated glucose metabolism.
    Chen HF; Wu LX; Li XF; Zhu YC; Wang WX; Xu CW; Huang ZZ; Du KQ
    Cell Mol Biol (Noisy-le-grand); 2019 Apr; 65(4):48-52. PubMed ID: 31078152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-inducible transcription factor-1alpha promotes hypoxia-induced A549 apoptosis via a mechanism that involves the glycolysis pathway.
    Luo F; Liu X; Yan N; Li S; Cao G; Cheng Q; Xia Q; Wang H
    BMC Cancer; 2006 Jan; 6():26. PubMed ID: 16438736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Qiliqiangxin attenuates hypoxia-induced injury in primary rat cardiac microvascular endothelial cells via promoting HIF-1α-dependent glycolysis.
    Wang Y; Han X; Fu M; Wang J; Song Y; Liu Y; Zhang J; Zhou J; Ge J
    J Cell Mol Med; 2018 May; 22(5):2791-2803. PubMed ID: 29502357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway.
    Gong T; Cui L; Wang H; Wang H; Han N
    J Transl Med; 2018 Jun; 16(1):164. PubMed ID: 29898734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wortmannin influences hypoxia-inducible factor-1 alpha expression and glycolysis in esophageal carcinoma cells.
    Zeng L; Zhou HY; Tang NN; Zhang WF; He GJ; Hao B; Feng YD; Zhu H
    World J Gastroenterol; 2016 May; 22(20):4868-80. PubMed ID: 27239113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Balanophorin B inhibited glycolysis with the involvement of HIF-1α.
    Dai T; Li L; Qi W; Liu B; Jiang Z; Song J; Hua H
    Life Sci; 2021 Feb; 267():118910. PubMed ID: 33359671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-inducible factor-1alpha promotes nonhypoxia-mediated proliferation in colon cancer cells and xenografts.
    Dang DT; Chen F; Gardner LB; Cummins JM; Rago C; Bunz F; Kantsevoy SV; Dang LH
    Cancer Res; 2006 Feb; 66(3):1684-936. PubMed ID: 16452228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impairment of HIF-1α-mediated metabolic adaption by NRF2-silencing in breast cancer cells.
    Lee S; Hallis SP; Jung KA; Ryu D; Kwak MK
    Redox Biol; 2019 Jun; 24():101210. PubMed ID: 31078780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin inhibits pancreatic cancer cell proliferation by regulating Beclin1 expression and inhibiting the hypoxia-inducible factor-1α-mediated glycolytic pathway.
    Guo W; Ding Y; Pu C; Wang Z; Deng W; Jin X
    J Gastrointest Oncol; 2022 Dec; 13(6):3254-3262. PubMed ID: 36636058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymoquinone Selectively Kills Hypoxic Renal Cancer Cells by Suppressing HIF-1α-Mediated Glycolysis.
    Lee YM; Kim GH; Park EJ; Oh TI; Lee S; Kan SY; Kang H; Kim BM; Kim JH; Lim JH
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30832444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decursin promotes HIF-1α proteasomal degradation and immune responses in hypoxic tumour microenvironment.
    Ge Y; Yoon SH; Jang H; Jeong JH; Lee YM
    Phytomedicine; 2020 Nov; 78():153318. PubMed ID: 32896707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wogonin reverses hypoxia resistance of human colon cancer HCT116 cells via downregulation of HIF-1α and glycolysis, by inhibiting PI3K/Akt signaling pathway.
    Wang H; Zhao L; Zhu LT; Wang Y; Pan D; Yao J; You QD; Guo QL
    Mol Carcinog; 2014 Feb; 53 Suppl 1():E107-18. PubMed ID: 23761018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Albendazole inhibits HIF-1α-dependent glycolysis and VEGF expression in non-small cell lung cancer cells.
    Zhou F; Du J; Wang J
    Mol Cell Biochem; 2017 Apr; 428(1-2):171-178. PubMed ID: 28063005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and functional evaluation of a novel HIF inhibitor, benzopyranyl 1,2,3-triazole compound.
    Park K; Lee HE; Lee SH; Lee D; Lee T; Lee YM
    Oncotarget; 2017 Jan; 8(5):7801-7813. PubMed ID: 27999195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.